Vontobel Holding Ltd. Generation Bio Co. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jun 03, 2024	SELL	$3.5 - $5.67 $99,155 - $160,631	-28,330 Reduced 7.36%	356,740 $1.96 Million
Q2 2023 Jul 24, 2023	SELL	$3.5 - $5.67 $99,155 - $160,631	-28,330 Reduced 7.36%	356,740 $1.96 Million
Q1 2023 Jun 03, 2024	BUY	$3.61 - $7.01 $1.39 Million - $2.7 Million	385,070 New	385,070 $1.66 Million
Q1 2023 Apr 12, 2023	BUY	$3.61 - $7.01 $401,731 - $780,093	111,283 Added 40.65%	385,070 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$3.66 - $6.77 $1 Million - $1.85 Million	273,787 New	273,787 $1.08 Million

49.6M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $56.1M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.